Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN

NCT06731335 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT06731335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06731335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN
Lead sponsor
Unity Health Toronto
Phase
Phase 2
Overall status
Recruiting
Start date
March 5, 2025
Completion date
December 31, 2026
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic neuropathic pain, pain management